Clinical trials

13

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Diabetes mellitus (DM), prediabetes, and obesity are emerging as major global public health problems, with their epidemic spread continuously increasing over the past decades. The occurrence of diabetic retinopathy, cataract, glaucoma, and ocular surface disease in patients with diabetes mellitus has been extensively investigated in several studies. However, mild ocular surface disorders, such as dry eye disease, have often been overlooked, with a previous study showing that 51.3% of diabetes-related dry eye disease cases remained underdiagnosed. Among systemic diseases, diabetes mellitus and obesity have been associated with an increased risk of developing dry eye disease. Chronic hyperglycemia in diabetes leads to microvascular damage, including corneal neuropathy and reduced tear production, conditions that can disrupt ocular surface health, while systemic inflammation and meibomian gland dysfunction also contribute to this process. However, the effect of newer classes of antidiabetic medications, including glucagon-like peptide-1 receptor agonists (GLP-1 RAs), on ocular surface health remains insufficiently understood. The aim of this prospective cohort study is to evaluate the effects of GLP-1 receptor agonists on dry eye disease in patients with type 2 diabetes mellitus and obesity through the assessment of ocular surface parameters, such as tear film break-up time, Schirmer test results, as well as potential changes in corneal topography.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Attikon HospitalUpdated: Jun 2, 2026Locations: 1
Eligibility criteria

Age ≥18 years. [+2]

Pregnant or breastfeeding patients. [+5]

Status: Recruiting

Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial)

Approximately 20-30% of patients experience persistent pain after a Total Knee Arthroplasty (TKA). This study investigates whether percutaneous cryoneurolysis of genicular nerves can reduce pain and improve physical function when performed at least 24 hours before surgery. Participants will be randomized to receive either the cryoneurolysis procedure + TKA or TKA only. Results will be tracked for 6 months to see if the intervention improves long-term recovery and quality of life.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Attikon HospitalUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Adults ≥18 years undergoing primary TKA for osteoarthritis. [+2]

Cancer-related knee pain. [+2]

Status: Recruiting

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

The aim of the present study is to investigate a) the presence of subclinical markers of vascular, myocardial and endothelial function in women with PCOS b) the acute alterations in these markers during the oral glucose tolerance test (OGTT) c) the impact of potential treatment interventions in these markers.

Participants needed: 120
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Attikon HospitalUpdated: Nov 19, 2025Locations: 1
Eligibility criteria

Age > 16 years old [+5]

Disorders with clinical presentation similar to PCOS: thyroid disease, hyperprol... [+6]

Status: Recruiting

Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference

In this observaltional study, 240 patients aged \>12 years old with T1DM who are on multiple daily injections or insulin pump and are scheduled to start using MiniMed 780G system will be included.We aim to compare patients' adherence to Mediterranean diet (MD) before and 12 weeks after initiation of MiniMed 780G and its association with CGM and insulin metrics, as well as anthropometric measurements, BMI, body composition, lipid levels, blood pressure and gut microbioma. Moreover, at baseline, at six and 12 months, markers of endothelial and cardiovascular function will be also assessed and associated with the use of Minimed 780G and the adherence to MD.

Participants needed: 240
Trial details
Age: 12-80Biological sex: AllType: ObservationalSponsor: Attikon HospitalUpdated: Nov 19, 2025Locations: 1Duration: 12 Months
Eligibility criteria

Clinical diagnosis of type 1 diabetes >1 year prior to consent date. Diagnosis o... [+5]

Status: Recruiting

Effects of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries

The aim of this study is to examine the effects of intraoperative systemic use of dexmedetomidine on the intraocular pressure (IOP) in patients undergoing spine surgeries in a prone position under general anesthesia.

Participants needed: 60
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Attikon HospitalUpdated: Sep 30, 2025Locations: 1
Eligibility criteria

Adult patients undergoing scheduled spine surgery performed in prone position un...

Patients who refuse to be a part of the study [+4]

Status: Recruiting

The Value of EEG in Stroke Units

Τhe aim of the study is to investigate the role of EEG both in predicting epileptogenesis in patients with acute stroke and in detecting and clarifying the clinical significance of subclinical epileptic seizures in a stroke unit. More specifically, the performance of routine EEG in patients with ischemic or hemorrhagic stroke who are hospitalized in the Stroke Unit within the first days after the event, regardless of the presence of clinical indications, and the identification of risk factors for the early development of epilepsy in the course of these patients' disease constitute the central research question. The identification of patients with subclinical electroencephalographic seizures and the impact of such events on functional outcome, as well as their association with the development of epilepsy, are set as secondary research objectives.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Attikon HospitalUpdated: Sep 24, 2025Locations: 1Duration: 2 Years
Eligibility criteria

Not listed

Status: Recruiting

A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases

The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.

Participants needed: 15
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Attikon HospitalUpdated: May 31, 2025Locations: 2
Eligibility criteria

Age 18-80 [+4]

Diabetes mellitus [+5]

Status: Recruiting

NOL Guided Analgesia During Elective Laparoscopic Surgery Under General Anesthesia

The aim of this study is to investigate the hypothesis that the intraoperative use of the nociception level index NOL can reduce opioid consumption in adult patients undergoing elective laparoscopic surgeries under general anesthesia, as well as to explore its effect on post-operative pain and patient recovery.

Participants needed: 50
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Attikon HospitalUpdated: Apr 3, 2025Locations: 1
Eligibility criteria

Adult patients undergoing planned laparoscopic surgery under general anesthesia.

Emergency surgery. [+9]

Status: Recruiting

GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms

This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols and Meditteranean diet (MED-LFD) in a small group of patients with Irritable Bowel Syndrome (IBS).

Participants needed: 100
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Attikon HospitalUpdated: Apr 6, 2025Locations: 1
Eligibility criteria

Fulfillment of the Rome IV criteria for IBS [+3]

Any concomitant disease requiring specialized nutrition (e.g. renal failure, dia... [+2]

Status: Recruiting

Dexmedetomidine Wound Infiltration in Cesarean Section

The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).

Participants needed: 100
Trial details
Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Attikon HospitalUpdated: Mar 19, 2025Locations: 1
Eligibility criteria

pregnancy >37 weeks, ASA I-II, BMI<35

patient refusal, epilepsy, GERD, morbid obesity, drug allergy, ASA class >2, pre...

Status: Not yet recruiting

The Association Between Time in Range With Markers of Endothelial and Cardiovascular Function

In this observaltional study, 90 patients aged \>12 years old with T1DM who are on MiniMed 780G system will be included.We aim to investigate the association between time in range (70-140mg/dl) and time in tight range (70-180mg/dl) with markers of endothelial and cardiovascular function.

Participants needed: 90
Trial details
Age: 12-80Biological sex: AllType: ObservationalSponsor: Attikon HospitalUpdated: Feb 5, 2025
Eligibility criteria

Clinical diagnosis of type 1 diabetes >1 year prior to consent date. Diagnosis o... [+5]

Status: Recruiting

Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD

Irritable bowel syndrome (IBS) is a highly prevalent chronic functional gastrointestinal disorder. The cardinal symptoms include abdominal pain, flatulence, bloating, and changes in bowel habits related to stool frequency and consistency, in the absence of detectable structural and biochemical abnormalities1,2. The prevalence is estimated at 5-10% among different ethnicities3. A low FODMAP diet is the most common dietary intervention with clinically proven benefits in symptom management and quality of life improvement of patients with Irritable Bowel Syndrome (IBS)4. Recently, a dietary digestive enzyme formulation (FODZYME©) claims similar efficacy in symptom management based on an ex-vivo study5. The study aims to examine the clinical efficacy of this formulation in managing IBS symptoms in patients who have previously clinically responded to a low FODMAP diet.

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Attikon HospitalUpdated: Jan 7, 2025Locations: 2
Eligibility criteria

Provision of written informed consent. [+3]

Patients who did not take part in the aforementioned study [+2]

Status: Recruiting

Prospective Evaluation of Ultrasound-guided Percutaneous Cholecystostomy With the Trocar Technique

The purpose of this study is to further evaluate and investigate the safety and efficacy of ultrasound (US)-guided percutaneous cholecystostomy (PC) with the trocar technique by the patient's bedside.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Attikon HospitalUpdated: Mar 26, 2024Locations: 1Duration: 3 Months
Eligibility criteria

All patients requiring PC, irrespective of the underlying cause and indication,...

Patients are going to be excluded from the study if they are younger than 18 yea...